Skip to content
Home/Companies/Biotech/Corteria Pharmaceuticals
CP

Corteria Pharmaceuticals

Biotech·France·Active·3yr hold

Corteria Pharmaceuticals is a healthcare company, headquartered in France.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns Corteria Pharmaceuticals?

Corteria Pharmaceuticals is currently owned by Jeito Capital through Jeito I (2021 vintage), since 2023. Across its history, Corteria Pharmaceuticals has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Jeito Capital
Most recent investor
Jeito Capital
Jeito I · 2021 · VC
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Omnes Capital and Jeito Capital since 2021.
Co-invest · 2 holders · 2021 · present
Omnes Capital
Omnes CapitalActive
2021 · present · Omnes Real Tech 1 · 2018 · VC
MOIC
–
Jeito Capital
Jeito CapitalActive
2023 · present · Jeito I · 2021 · VC
MOIC
–

More from Jeito I

Other portfolio companies in the same fund.

Noema Pharma
Active
BiotechSwitzerland· 2023
Advesya
Active
BiotechSpain· 2022
CatalYm
Active
BiotechGermany· 2022
CDR-Life
Active
BiotechSwitzerland· 2022
EyeBio
Exited 2024
BiotechUS· 2022
to
NMD Pharma
Active
BiotechDenmark· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings